niacin and sorafenib
niacin has been researched along with sorafenib in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ahmed, EM; El-Dash, Y; Gowifel, AMH; Hassan, MSA; Hassanin, SO; Khalil, NA | 1 |
Reviews
1 review(s) available for niacin and sorafenib
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
1 other study(ies) available for niacin and sorafenib
| Article | Year |
|---|---|
Synthesis of novel nicotinic acid derivatives of potential antioxidant and anticancer activity.
Topics: Antineoplastic Agents; Antioxidants; Cell Proliferation; Doxorubicin; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Neoplasms; Niacin; Protein Kinase Inhibitors; Sorafenib; Structure-Activity Relationship; Superoxide Dismutase; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2023 |